Ying Zhou

Ying Zhou, PhD, is currently the Global President and CTO at ReLive Biotechnologies Limited and the Managing Director at CO.DON GmbH. Prior to these roles, Ying served as a Sr. Scientist to Director at Alkermes, focusing on Drug Discovery and Early Development. Ying also worked as a Project Leader in Proteomics & Drug Discovery at AmberGen Inc., where they were awarded a 3-year Phase II SBIR grant from NIH-NIGMS. With a strong educational background in Biochemistry, Analytical Chemistry, and Chemistry, Ying brings valuable expertise and leadership to the biotechnology industry.